angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with Cognition Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fidalgo, S; Gard, PR; McIver, A; Quadir, A; Skipper, C; Takyi, A; Tsiligkaridis, T | 1 |
| Ho, JK; Nation, DA | 1 |
| Hallberg, M | 1 |
2 review(s) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Cognition Disorders
| Article | Year |
|---|---|
Cognitive benefits of angiotensin IV and angiotensin-(1-7): A systematic review of experimental studies.
Topics: Angiotensin I; Angiotensin II; Animals; Cognition Disorders; Databases, Bibliographic; Dementia; Disease Models, Animal; Humans; Memory, Short-Term; Peptide Fragments | 2018 |
Targeting the insulin-regulated aminopeptidase/AT4 receptor for cognitive disorders.
Topics: Alzheimer Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cognition Disorders; Cystinyl Aminopeptidase; Drug Delivery Systems; Drug Discovery; Humans; Ligands; Models, Biological; Molecular Structure; Receptors, Angiotensin | 2009 |
1 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Cognition Disorders
| Article | Year |
|---|---|
Low-dose chronic prenatal alcohol exposure abolishes the pro-cognitive effects of angiotensin IV.
Topics: Angiotensin II; Animals; Body Weight; Central Nervous System Depressants; Cognition Disorders; Ethanol; Exploratory Behavior; Female; Locomotion; Male; Maze Learning; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Recognition, Psychology; Sex Factors; Statistics, Nonparametric | 2017 |